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Abstract Chemical components of air pollutant exposures
that induce oxidative stress and subsequent inflammation may
be partly responsible for associations of cardiovascular
morbidity and mortality with airborne particulate matter and
combustion-related pollutant gasses. However, epidemiologic
evidence regarding this is limited. An exposure-assessment
approach is to measure the oxidative potential of particle
mixtures because it is likely that hundreds of correlated
chemicals are involved in overall effects of air pollution on
health. Oxidative potential likely depends on particle compo-
sition and size distribution, especially ultrafine particle
concentration, and on transition metals and certain semi-
volatile and volatile organic chemicals. For health effects,
measuring systemic oxidative stress in the blood is one
feasible approach, but there is no universal biomarker of
oxidative stress and there are many potential target molecules
(lipids, proteins, DNA, nitric oxide, etc.), which may be more
or less suitable for specific study goals. Concurrent with the
measurement of oxidative stress, it is important to measure
gene and/or protein expression of endogenous antioxidant
enzymes because they can modify relations between oxidative
stress biomarkers and air pollutants. Conversely, the expres-
sion and activities of these enzymes are modified by oxidative
stress. This interplay will likely determine the observed effects
of air pollutants on systemic inflammatory and thrombotic
mediators and related clinical outcomes. Studies are needed to
assess the reliability and validity of oxidative stress bio-
markers, evaluate differences in associations between oxida-
tive stress biomarkers and various pollutant measurements
(mass, chemical components, and oxidative potential), and
evaluate impacts of antioxidant responses on these relations.
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Overview
Cardiovascular hospitalization and mortality have been con-
sistently associated with increased exposure to airborne mass
concentrations of particulate matter (PM)<2.5μm (PM2.5) and
<10 μm in diameter (PM10) (Pope and Dockery 2006; Brook
et al. 2010). Although epidemiologic studies have shown
associations of cardiovascular morbidity and mortality with
ambient CO and NO2 (Brook et al. 2010; Bhaskaran et al.
2009), concentrations of these gasses have been considerably
lower relative to levels causing effects in experimental
models, and it is possible that these gasses are serving as
surrogates for other causal components from fossil fuel
combustion. A recent review also reports lack of consistent
findings in time series studies for the relation of ozone to
daily hospital data for myocardial infarction (Bhaskaran et al.
2009). Together, these findings call for the need to better
understand the underlying causal chemical components and
pathophysiological mechanisms responsible for the morbidity
and mortality associations (Mills et al. 2009).
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Oxidative stress responses to reactive oxygen species
(ROS) and subsequent inflammation resulting from air
pollution exposuremay be one of these important mechanisms
(Brook et al. 2010; Frampton 2006; Xia et al. 2006).
However, epidemiologic evidence in humans that ambient
PM or gaseous pollutant exposures increases biomarkers of
oxidative stress is limited. The following review assesses the
importance of addressing this gap to the field of air pollution
research and we offer some possible methods of doing so by
focusing on a few selected biomarkers that can be measured
in the blood for large population studies. We will not discuss
the use of other body fluids to measure oxidative stress that
are reviewed elsewhere, for example exhaled breath con-
densates (Silkoff et al. 2006) and urine (Cooke et al. 2002).
We also focus on inhalation and pulmonary deposition as the
route of exposure for cardiovascular effects of interest in the
paper (we do not discuss dermal, gastrointestinal, or
transplacental routes). Finally, the air pollutants of primary
focus in the review are those associated with particles.
Oxidative stress, inflammation, and air pollution
exposures
Oxidative stress is a biochemical imbalance in which
production of ROS exceeds the natural antioxidant capacity.
This imbalance can occur in the body following exposure to
pro-oxidant air pollutants (Fig. 1). Given this balance between
oxidants and antioxidants, a threshold level for exposure to
the pro-oxidant pollutant might be expected to lead to a
measurable oxidative stress response. In the presence of
oxidative stress, uncontained ROS cause tissue damage and
dysfunction by attacking and denaturing structural and
functional molecules (lipids, proteins, carbohydrates, DNA,
RNA, NO, etc.) and by modulating the activities of redox-
sensitive transcription factors (e.g., nuclear factor kappa-light-
chain-enhancer of activated B cells (NFκB), AP-1, and signal
transduction pathways). In general, the first line of defense
against oxidative stress is via antioxidant enzymes and
proteins involved in phase II detoxification. This response
is regulated by the nuclear factor-erythroid 2-related factor 2
(Nrf2)/antioxidant-response element (ARE) pathway. The
pathway is activated when signals from oxidative and
electrophilic chemicals modify Kelch-like ECH associated
protein 1 to release Nrf2, which then moves to the nucleus
and activates the expression of genes with ARE that include
antioxidant and phase II genes. This is a key pathway in
responses to toxic pollutants (Kensler et al. 2007), and is
important in mitigating oxidative stress-induced endothelial
dysfunction (Mann et al. 2007). When these defense
mechanisms are overwhelmed at higher levels of exposure-
induced oxidative stress, pro-inflammatory effects follow via
the activation of NFκB. Activation of NFκB increases the
transcription of chemokines, cytokines and acute phase
proteins that contribute to and are predictive of coronary
artery disease risk (Pai et al. 2004). Nitrosative stress from
reactive nitrogen species (RNS) such as peroxynitrite may
also be an important driver of inflammatory responses
(Shishehbor et al. 2003). Finally, cytotoxic effects could
occur at higher levels of exposure (Ayres et al. 2008).
Extensive data show linkages of oxidative stress and
depressed antioxidant capacity with the risk of cardiovas-
cular disease (Dhalla et al. 2000), hypertension (Vaziri and
Rodríguez-Iturbe 2006), and chronic kidney disease (Vaziri
2004). Oxidative stress may play a central role in the
respiratory and cardiovascular effects of air pollution
through its immunomodulating effects and its ability to
initiate the inflammatory process and thrombogenic activity
(Dhalla et al. 2000). Experimental data shows that redox
active PM components (that are especially enriched in
ultrafine PM<0.1 μm) lead to the production of ROS in
various cells in the lungs, blood and vascular tissues. This
is followed by oxidative stress, which can then lead to
increased airway and systemic inflammation, and adverse
cardiovascular responses when antioxidant defenses are
overwhelmed (Ayres et al. 2008; Utell et al. 2002).
Epidemiologic data directly supporting this experimental
evidence is limited, but there is indirect support from
studies that have examined the effect modification of
responses to air pollutant exposures by variants in oxidative
stress-related genes (Alexeeff et al. 2008; Chahine et al.
2007; Islam et al. 2008, 2009; Park et al. 2006; Ren et al.
2010; Schwartz et al. 2005).
There is also some epidemiologic evidence that PM
exposure significantly increases biomarkers of oxidative
stress in blood, but the data are limited for susceptible
populations exposed to urban air pollution. The epidemio-
logic evidence include panel studies of healthy subjects
with few repeated measures (Chuang et al. 2007; Liu et al.
2007; Sørensen et al. 2003, 2005; Vinzents et al. 2005), and
studies of workers occupationally exposed to combustion
aerosols (Autrup et al. 1999; Kim et al. 2004; Lai et al.
2005; Rossner et al. 2007, 2008a, b; Sharman et al. 2002;
Singh et al. 2007). The oxidation of low density lipoprotein
(ox-LDL) has been found to be increased among people
exposed to environmental tobacco smoke (Panagiotakos et
al. 2004), which may carry redox active components similar
to those in urban air.
Urban air pollution has been linked to increased ox-LDL
in mice (Soares et al. 2009) and impairment of the anti-
inflammatory capacity of high density lipoprotein (HDL) in
mice (Araujo et al. 2008). This effect may play a role in the
pro-atherosclerotic effects of air pollution that have been
found using experimental models (Araujo and Nel 2009;
Chen and Nadziejko 2005; Sun et al. 2005; Suwa et al.
2002), and have been evidenced in epidemiologic studies
38 Air Qual Atmos Health (2011) 4:37–52
showing increased risk of atherosclerotic lesions among
subjects living near busy traffic (Hoffmann et al. 2007;
Künzli et al. 2005, 2010).
The importance of endogenous antioxidants to air
pollutant responses
Evidence for the important role of antioxidant reactions
(discussed below) in vivo is that alterations in antioxidant
enzyme activities have been associated with cardiovascular
(Espinola-Klein et al. 2007; Förstermann 2008; Fukai et al.
2002), renal (Vaziri 2004; Vaziri et al. 2009), and respiratory
disease pathologies (Rahman et al. 2006). More recently,
meta-analyses of published human studies identified a
strong, inverse association of superoxide dismutase (SOD),
glutathione peroxidase (GPx-1), and catalase enzyme activ-
ities in blood with coronary artery disease risk in people
(Flores-Mateo et al. 2009). Such chronic antioxidant enzyme
deficiencies raise the susceptibility to and increase the
severity of tissue injury in response to oxidative stress.
However, acutely, up-regulation of antioxidant enzymes can
be a marker of responses to pollutant exposures denoting
ROS/electrophile-induced Nrf2 activation.
The antioxidant activity of key proteins can also be used as
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Fig. 1 Stress response pathways.
Air pollutant effects may occur in
large part through the generation
of ROS or reactive nitrogen spe-
cies (RNS) from organic chem-
icals either directly from air
pollutant components, or through
activation of bronchial epithelial
cells, macrophages, neutrophils,
and endothelial cells (specific
details in text). Air pollutant com-
ponents from fossil fuel combus-
tion including polycyclic aromatic
hydrocarbons (PAH), quinones,
and transition metals (e.g., Fe)
have pro-oxidant properties and
may induce oxidative stress
through the production of free
radicals and subsequent activation
of redox-sensitive signaling path-
ways (e.g., Nrf2, ARE, NF-κB).
These pathways may be behind
findings indicating that exposure
to fine particles trigger inflamma-
tory and cytotoxic responses in the
human lung as well as systemic
inflammation and thrombosis
when oxidant defenses are inade-
quate. Systemic oxidative stress
and inflammation may occur as a
result of effects of pollutants on the
airways (indirect pathway) or from
the direct systemic distribution of
pollutant chemicals following pul-
monary deposition
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assumption that it is a protective response. For example, this
approach has been used with heme oxygenase-1 (HO-1) gene
and protein expression in leukocytes exposed in vitro to
particle mixtures (Li et al. 2002). HO-1 catalyzes the first step
in heme degradation, and produces a general response to
oxidative stress induced by ROS via the production of
biliverdin which is a potent antioxidant molecule (Ryter et al.
2006).
Other key antioxidant enzymes include the glutathione
S-transferases (GSTM1, GSTT1, and GSTP1), which are
critical for the detoxification of xenobiotics including
polycyclic aromatic hydrocarbons (PAH)-epoxides (phase
II reactions) through the mercapturic acid pathway (Keen
and Jakoby 1978). They also protect cells from protein,
lipid and DNA oxidation products by the conjugation of
harmful electrophiles to glutathione (GSH) (Bogaards et al.
1997; Hayes and McLellan 1999; Hayes et al. 2005). In
human lung epithelial cells and in leukocytes, GSTP1
contributes most GST-derived enzyme activity, whereas
GSTM1 is highly expressed in lymphoid cell lines and
GSTT1 in erythroid cell lines (Fryer et al. 1986; Wang et al.
2000).
Oxidant air pollutants can also induce NADPH quinone-
oxidoreductase (NQ01) expression. NQ01 detoxifies highly
reactive quinones to hydroquinones (Monks et al. 1992),
but some of these hydroquinones may still be reactive
(Ross et al. 2000).
Mitochondrial manganese superoxide dismutase (MnSOD),
extracellular Cu,Zn-SOD (extracellular SOD), cytosolic Cu,
Zn-SOD, GPx-1, and catalase (CAT) are part of the frontline
defense against ROS. SOD converts superoxide radicals to
H2O2, whereas CAT and GPX1 catalyze the reduction of
H2O2 to water and molecular oxygen. Superoxide anion
scavenging activity in erythrocytes is driven largely by
cytosolic Cu,ZnSOD since they lack mitochondria.
extracellular SOD is the predominant SOD isoenzyme in
plasma and its gene is 60% homologous with cytosolic Cu,
ZnSOD, but is minimally homologous to mitochondrial
MnSOD. It is highly expressed in arterial walls, where it is
produced predominantly by smooth muscle cells (Fattman et
al. 2003). Diminished expression of extracellular SOD may be
important in the progression of coronary artery disease (Fukai
et al. 2002) and may play an important role in endothelial
dysfunction in patients with this disease (Landmesser et al.
2000). Specifically, endothelial NO synthase produces NO,
which traverses the extracellular space to induce smooth
muscle relaxation in the vessel wall. Superoxide can react
with NO to form the potent oxidant, peroxynitrite, which is
likely involved in lipid peroxidation (O’Donnell and Freeman
2001). Gurgueira et al. (2002) found that rats exposed to
concentrated ambient particles showed an adaptive increase in
Cu,Zn-SOD activity in heart but not lung tissue. However, the
standard colorimetric measurement of Cu,Zn-SOD activity
does not distinguish between extracellular and cytosolic Cu,
Zn-SOD (which predominates in erythrocytes and other cell
types) potentially invalidating the measurement of extracellu-
lar SOD in plasma. Low hemolysis after blood cell separation
could result in an overestimation of SOD as well as GPx in
plasma.
Paraoxonase-1 (PON1) is an antioxidant enzyme that
contributes to the antioxidant property of HDL by
reversing/preventing lipid peroxidation, particularly peroxi-
dation on LDL (Watson et al. 1995), and by limiting
production of oxidized arachidonic acid-derived products
that lead to the formation of 8-isoprostane (Adkins et al.
1993). The antioxidant properties of PON1 are based on its
capacity to hydrolyze lipid peroxidation products (Mackness
et al. 1998).
Production of several other enzymes capable of promoting
oxidative stress may be induced by pollutant chemicals or
particles that interact with cells. For example, myeloperox-
idase which is released by activated neutrophils, monocytes,
and some macrophages can damage lung (Repine et al. 1997;
Gilliland et al. 1999) and arterial tissue (Schindhelm et al.
2009) by producing potent oxidants such as hypochlorous
acid. Macrophages produce ROS as well in response to
particle exposures. The cytochrome P450 (CYP) family is
also important in the generation of ROS by activating
inhaled toxicants via reductase-catalyzed quinone reduction
(phase I reactions) (Kumagai and Shimojo 2002; Fig. 1).
Microsomal epoxide hydrolase 1 as such acts in association
with CYP enzymes by metabolizing PAH to highly reactive
epoxide intermediates, which lead to ROS generation
(Decker et al. 2009). The above data regarding cell-based
pro-oxidant responses has led to the suggestion that
inflammatory cell cultures may serve as indicators of the
oxidative potential of particle mixtures via in vitro test
systems that measure ROS production (discussed below;
Ayres et al. 2008).
In addition to endogenous antioxidant enzymes and ROS
scavenger molecules, exogenous dietary antioxidants may
also protect people from the adverse effects of oxidative stress
by up-regulating endogenous antioxidant defenses (or acting
as cofactors), and by their own antioxidant properties (Romieu
et al. 2008). However, their importance relative to the
endogenous system itself is controversial (Limón-Pacheco
and Gonsebatt 2009; Viña et al. 2007; Wenger 2007).
Finally, several drugs used in the treatment of cardiovas-
cular diseases, especially statins (cholesterol-lowering medi-
cations), may inhibit the progression of atherosclerosis by their
anti-inflammatory and anti-oxidant properties (Adameova
et al. 2009). This may be relevant to findings in several
cohort panel studies that show weaker associations between
circulating biomarkers of inflammation and air pollution
among subjects using statins (Delfino et al. 2009; Dubowsky
et al. 2006; O’Neill et al. 2007; Ruckerl et al. 2006).
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Oxidative stress and post-translational modification
of proteins
ROS and RNS can lead to many different types of post-
translational modifications of proteins including electrophilic
modifications, protein carbonlyation, S-glutathionylation,
oxidation of methionine residues, nitration, and hydroxylation
of amino acids, oxidation of sulfhydryl groups, etc. (Gianazza
et al. 2007). These effects have functional implications
including inactivation of proteins, and downstream effects
such as epigenetic changes. For example, S-glutathionylation
occurs under oxidative conditions when a disulfide bond is
made between a cysteinyl residue of a protein and
oxidized glutathione disulfide (GSSG), or with GSH via
one of the GSTs, and is reversed by thiol-disulfide
oxidoreductase enzymes. This is important in redox
signal transduction, in the regulation of c-Jun, JNK,
and TRAF2 (apoptotic and proliferative effects), redox-
sensitive thiol proteins, and proteins involved in the
folding and maturing of transmembrane and secretory
proteins in the endoplasmic reticulum (ER; Mieyal et al.
2008; Townsend 2007). S-glutathionylation may be a
regulator of an accumulation of misfolded or unfolded
proteins secondary to an increased redox state in the ER
(ER stress) resulting in an adaptive response (unfolded
protein response), which if prolonged leads to apoptosis
(Townsend 2007). Indirect evidence that this biological
pathway can be influenced by air pollutant-induced
oxidative stress comes from several experimental studies
that have found exposure to urban PM or diesel exhaust
particles leads to upregulation of unfolded protein
responses in cells from in vitro cell cultures and from
lung and liver tissue of exposed mice (Gong et al. 2007;
Laing et al. 2010; Watterson et al. 2009).
Oxidative stress and ROS may also lead to epigenetic
changes including changes in the methylation of DNA and
post-translational modifications of histones (methylation,
tyrosine nitration, phosphorylation, ubiquitination, and
SUMOylation), which may then affect gene expression
and thus protein expression. For example, in the case of
corticosteroid resistance, peroxynitrite nitrates tyrosine
residues on histone deacetylase-2 leading to its inactivation
and subsequent decrease in its ability to deacetylate
histones. This in turn leads to the increased expression of
the inflammatory genes associated with the histones
(Barnes 2009).
Inactivation of antioxidant enzymes by electrophilic air
pollutants chemicals could also be an important mechanism
of air pollutant-induced oxidative stress. In a repeated
measures analysis of 60 elderly subjects with a history of
coronary artery disease, we found inverse associations of
air pollutants (especially ultrafine particles and markers of
primary combustion) with the activities of key erythrocyte
antioxidant enzymes (GPx-1 and Cu,Zn-SOD; Delfino et al.
2008, 2009, 2010a). However, sensitivity analyses showed
a small group of seven subjects with strongly positive
associations (Delfino et al. 2009). Antioxidant enzymes in
erythrocytes such as GPx-1 and Cu,Zn-SOD are important
in protection against oxidative stress (Cimen 2008; Minetti
et al. 2007; Tsantes et al. 2006). Whereas increased
antioxidant proteins through the induction of genes is
expected in nucleated cells (e.g., leukocytes) in response
to oxidative stress, erythrocytes are unable to do so. It is
possible that certain particle components can inactivate
enzymes due to their electrophilic properties. We hypoth-
esized that erythrocyte antioxidant enzyme inactivation by
electrophilic components in air pollution is a possible
explanation for our findings. Oxidative stress would be
more likely as a result. Specifically, erythrocyte antioxidant
inactivation could lead to pollutant-related increase in
biomarkers of inflammation such as interleukin-6, which
we also found was positively associated with air pollutants
(Delfino et al. 2009). Interestingly, GPx-1 was also
inversely associated with interleukin-6.
In vitro data has shown enzyme inactivation by pollutant
components or ultrafine particles (Hatzis et al. 2006; Pigeolet
et al. 1990). We recently conducted preliminary in vitro tests
that showed pollutant-induced inactivation of the GPx-1
enzyme (Staimer et al. 2010). Compared with control
conditions, GPx-1 activity significantly decreased when
treated with an electrophilic chemical (p-Benzoquinone)
and with extracts of PM2.5 particles collected on quartz
filters at a downtown Los Angeles monitoring location.
Other in vitro studies have shown irreversible inactivation of
the thiol enzyme GAPDH by extracts of concentrated
ambient ultrafine particles and diesel exhaust particles
(Shinyashiki et al. 2008, 2009) as well as vapor phase
ambient chemicals (Eiguren-Fernandez et al. 2010; Iwamoto
et al. 2010). Some electrophilic chemicals in traffic exhaust
are anticipated to lead to the inactivation of enzyme’s
catalytic activity by covalent bond formation with nucleo-
philic (electron donor) functions of proteins. Enzyme
inactivation may also occur through oxidation of protein
cysteine residues by oxidant chemicals in vehicular emis-
sions leading to irreversible oxidation products (Kumagai
and Shimojo 2002).
Importance of particle size and composition to oxidative
stress responses
In vitro data suggests that organic constituents and
transition metals (e.g., Fe, Cu, Ni, and Zn) in PM are
capable of generating ROS directly (Ayres et al. 2008; Cho
et al. 2005; Ntziachristos et al. 2007) or as a result of their
capacity to activate neutrophils or other leukocytes, alveolar
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macrophages, respiratory epithelial cells, and endothelial
cells. Transition metals have known potential to induce
oxidative stress through Fenton reactions. Cellular genera-
tion of ROS from exposure to PM mixtures has been
demonstrated using an in vitro system of rat alveolar
macrophages (Verma et al. 2009a, b). Important reactive
chemicals may include PM2.5 organic components such as
quinones that are themselves oxidizing species or PAH that
undergo bio-transformation by cytochrome P-450 1A1 to
quinones, which can induce oxidative stress (Bonvallot et
al. 2001). Diesel exhaust particles are enriched in these
redox cycling components (Shinyashiki et al. 2009).
Automobile exhaust produces nearly the same set of
components (Phuleria et al. 2007) and is responsible for a
majority of mobile-source PM emissions in the USA
(Gertler 2005).
Experimental data show that PAH and oxidized PAH (e.g.,
quinones) from diesel exhaust particles promote the genera-
tion of ROS leading to oxidative stress and NFκB activation
with resultant inflammatory responses (Riedl and Diaz-
Sanchez 2005). These exposures also lead to changes in
antioxidant enzyme expression as shown in studies of airway
responses in human subjects (Behndig et al. 2006) and with
in vitro data (Li et al. 2002).
Such effects may underlie epidemiologic findings (in-
cluding our own) of increased markers of vascular
hypercoagulability and circulating inflammatory markers
in relation to exposures to markers of traffic-related air
pollutants (e.g., elemental carbon) in cohort panel studies
(Delfino et al. 2008, 2009, 2010a, d; Ruckerl et al. 2006;
Yue et al. 2007), in cross-sectional studies (Madrigano et al.
2009; O’Neill et al. 2007). This view is supported by results
from a panel study of 60 elderly subjects described above
showing that associations of plasma interleukin-6 (IL-6)
and TNF-RII with PM0.25 mass were completely confound-
ed by the PAH fraction of PM0.25 (Delfino et al. 2010d).
Both indoor and outdoor home concentrations of low,
medium, and high molecular weight PAHs were signifi-
cantly associated with these biomarkers of systemic
inflammation. Chemical mass balance model results using
source tracers suggested that a majority of the PAH came
from vehicular sources (Arhami et al. 2010; Delfino et al.
2010d). Another interesting study found associations
between the traffic-related air pollutant, black carbon
(BC), with plasma homocysteine levels, which is a risk
factor for cardiovascular disease (Park et al. 2008). Authors
suggested mechanisms to explain their findings, including
an involvement of pollutant-generated ROS or inactivation
of enzymes involved in homocysteine remethylation. These
findings are consistent with a recent extensive review of the
literature that concluded “vehicular emissions are a major
environmental cause of cardiovascular mortality and mor-
bidity in the United States” and that a PM2.5 BC standard
should be considered under the US National Ambient Air
Quality Standards (Grahame and Schlesinger 2010).
Particle size fraction is also an important determinant of the
dose of redox active chemicals delivered to target organs. The
ultrafine (<0.1μm in diameter) and accumulationmodes (0.1–
2.5 μm) make up total PM2.5 mass (fine particles), which is
regulated by the US Environmental Protection Agency
(EPA). However, ultrafine particles are expected to induce
greater responses per unit mass than larger particles that
dominate PM2.5 mass. This has been attributed to higher
deposition and retention in the lungs, ability to evade
phagocytosis by surface macrophages, and magnitudes
higher particle number and surface area than larger particles,
thus delivering to the lungs greater concentrations of toxic
components (Ayres et al. 2008; Delfino et al. 2005; Mills et
al. 2009; Oberdörster et al. 2005; Schmid et al. 2009; Geiser
and Kreyling 2010). Because of this surface area, ultrafine
particles carry redox active organic chemicals (e.g., PAH)
and transition metals in much higher concentrations than
larger particles (Sioutas et al. 2005). Even for soot particles
with low organic content, ultrafine particle–cell interactions
can be an important pro-oxidant mechanism inducing
inflammatory responses, especially in the lungs, possibly
due to the large reactive surface area of carbon (Schmid et al.
2009). Therefore, toxic particle components and effective
surface area are not well-represented by EPA-regulated
PM2.5 and PM10.
Nevertheless, a few cohort panel studies still showed
associations of biomarkers of oxidative stress with PM2.5 or
PM10 mass (Chuang et al. 2007; Liu et al. 2007; Sørensen et
al. 2003). However, there is limited epidemiologic evidence in
humans relating well-characterized PM exposure to increases
biomarkers of oxidative stress in blood. Two small panel
cohort studies showed oxidative DNA damage (mainly 8-
oxodG) in lymphocytes from exposure to increased ultrafine
particle number concentrations (Vinzents et al. 2005) and PM
metals (Sørensen et al. 2005). However, sample sizes were
small in part due to the difficulty in performing the 8-oxodG
assay on freshly isolated lymphocytes.
Translocation of ultrafine particles into the circulation
has been shown in several studies, and despite the very low
overall rate of perhaps ≤1%, the effect on target organs may
be important given the high surface area and long retention
times (Schmid et al. 2009; Geiser and Kreyling 2010). The
high retention of ultrafine particles in the lungs shown in a
recent study (Möller et al. 2008) suggests that a much
greater impact is via the translocation of particle compo-
nents to the circulation. This may lead to sustained effects
through the gradual transfer of potentially redox active
components to the circulation over many days. This could
be particularly important for chemicals like PAH that
require biotransformation by phase I enzymes (Fig. 1).
Larger particles, including coarse particles, may have a
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greater impact in the lungs given that pro-inflammatory
components in fine or coarse particles are efficiently
delivered to the target airways. This is supported by an
experimental study showing that aspiration of coarse
particles collected both near and far from a busy highway
led to inflammatory responses in the lungs of mice whereas
only ultrafine particles from both locations led to cardiac
reperfusion injury (Cho and Kleeberger 2010). Results in
the cohort panel study described above for size-fractionated
particles showed that only quasi-ultrafine particles
<0.25 μm (PM0.25) were significantly associated with
systemic biomarkers of inflammation [IL-6 and tumor
necrosis factor-α receptor II] (Delfino et al. 2009) and with
ischemic ST-segment depression measured with ambulatory
electrocardiographs (Delfino et al. 2010c).
Furthermore, the potentially toxic components of carbo-
naceous aerosols are numerous and also vary considerably
by location and by time of day and season, many being
volatile during periods of low photochemical activity and
near sources. In particular, the effects of combustion-related
primary organic aerosols (POA) and their semivolatile
organic compounds (SVOC) such as PAH may differ from
effects of photochemically related secondary organic
aerosol (SOA), which are in part derived from aged primary
SVOC (Robinson et al. 2007). POA are formed during or
shortly (within seconds) after the combustion of fossil fuels
and are enriched in the ultrafine mode. SOA are formed
from gas-to-particle conversion when volatile reactive
organic gasses and SVOC are oxidized to form low-
volatility products that condense to produce SOA, which
is enriched in the accumulation mode (0.1–2.5 μm in
diameter). Although a large part of the regulatory effort to
protect public health involves regulating some of the gasses
involved in SOA formation, there is little data on the
importance of this characteristic of PM2.5 to cardiovascular
health. Given results from experimental studies in ApoE
mice (Campen et al. 2010; Lund et al. 2007), concentrations
of volatile and semi-volatile organic precursor components
from the combustion of fossil fuel are also likely important
determinants of vascular oxidative responses important in
the development of cardiovascular disease. However, there
is little data regarding this for ambient or traffic-related
exposures in human populations (Rossner et al. 2008a, b).
We have presented data showing that biomarkers of
systemic inflammation (Delfino et al. 2008, 2009, 2010a,
d), ambulatory blood pressure (Delfino et al. 2010b), and
ischemic ST segment depression in ambulatory ECG
(Delfino et al. 2010c) are more strongly associated with
POA than SOA exposure markers and chemical compo-
nents, whereas a biomarker of airway inflammation
(fractional exhaled NO) was more strongly associated with
SOA and ozone (Delfino et al. 2010d). We hypothesized
that many SOA components, which are hydrophilic and
highly oxidized, have immediate pro-oxidant effects on the
airways, whereas many POA components (e.g., PAH), are
hydrophobic and require biotransformation to pro-oxidant
species (this can occur after systemic distribution of these
chemicals). These findings do not support the belief that
activation of leukocytes in the lungs, followed by the
release of pro-inflammatory mediators is a major (indirect)
pathway to the systemic inflammatory effects of particulate
air pollution (Fig. 1; Mills et al. 2009).
Assessing the oxidative potential of PM components
This area of research has been extensively reviewed
elsewhere (Ayres et al. 2008) and will only briefly be
addressed here. The dithiothreitol (DTT) assay has been
used to assess the redox potential from organic components
in PM. The assay shows the capacity of PM to transfer
electrons from DTT to oxygen resulting in the generation of
superoxide. This redox activity is highest in ultrafine PM
and is strongly correlated with elemental carbon and PAH
fractions suggesting that traffic sources are important (Cho
et al. 2005). Several in vitro and in vivo animal studies
have shown that DTT activity of particle samples (along
with strongly correlated concentrations of PAH, oxy-PAH,
and polar organic chemicals) are related to ability of
ultrafine PM and diesel exhaust particles to induce oxidative
stress and inflammatory responses (Li et al. 2003, 2009;
Shinyashiki et al. 2009). However, another potentially
important mechanism of oxidative stress response to PM
chemicals is the production of ROS by cells. One
validated method is to assess this by incubation of rat
alveolar macrophages in vitro with particle extracts and
the ROS probe DCFH-DA under experimental conditions
where cell injury is negligible, and then measuring fluores-
cence intensity to represent the oxidative generating capacity
of particle extracts (Landerman et al. 2008). Macrophages are
the first line of defense against pulmonary injury, including
injury from pollutant particles. After phagocytizing particles,
macrophages generate ROS in an oxidative burst. This is
followed by cytokine cascades that result in inflammation
and additional ROS production. The cell-based ROS activity
induced by aqueous PM extracts in this assay has been
correlated with transition metal and OC concentration in
several studies in Los Angeles (Hu et al. 2008; Verma et al.
2009a) and elsewhere (Shafer 2010; Zhang et al. 2008). One
of the LA studies also showed greater ROS activity for
PM0.25 than larger particle size fractions (Hu et al. 2008).
We recently published among the first supportive
evidence for the use of PM oxidative potential as a
biomarker of exposure in epidemiologic research (Delfino
et al. 2010d). We evaluated the relation of airway and
systemic inflammatory responses to the potential of
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collected particles to induce cellular production of ROS.
Sixty elderly subjects were monitored with 12 weekly
measurements of both plasma IL-6 (a biomarker of
systemic inflammation) and offline fractional exhaled NO
(a biomarker of airway inflammation). To assess PM
oxidative potential, ROS production was measured as
described above (Landerman et al. 2008) by exposing rat
alveolar macrophages (NR8383) in vitro to aqueous
extracts of PM0.25 filters collected outdoors at the subjects’
retirement community. Both exhaled NO and IL-6 was
positively associated with levels of macrophage ROS
generation. Co-regression models of PM0.25 mass with
ROS production suggested that oxidative potential explained
most of the association of IL-6 with PM0.25 mass. The
association of exhaled NO with ROS activity was not
reflected by PM0.25 mass concentration. We concluded that
the ability of particles to induce ROS generation by
macrophages is associated with both systemic and airway
biomarkers of inflammation, and this association is nomi-
nally reflected by particle mass concentration.
Potentially useful biomarkers of oxidative stress status
There is no universal biomarker of oxidative stress or
oxidative status. Only a carefully selected panel of
markers tailored for specific study goals may reflect
different types of oxidative stress (Dotan et al. 2004).
Furthermore, no biomarker meets all the technical require-
ments (cheap, non-invasive, easy to detect, chemically and
biologically stable) as outlined by Dalle-Donne et al.
(2006). More specifically, rapid screening methods are
needed in large-scale epidemiological studies. Ideally,
these methods should be standardized and cost effective
with respect to biospecimen collection, processing, storage,
and analysis. Thus, some biomarkers are better suited for
epidemiologic studies than others. The following summarizes
some of the more widely used and feasible indices of
oxidative stress in large-scale human studies using blood
samples (based, in part, on Dotan et al. 2004; Dalle-Donne et
al. 2006, and Romieu et al. 2008) and highlights immuno-
chemical methods for biomarker detection when applicable.
Immunoassays are based on selective antibodies directed
towards specific target analytes and they continue to be the
method of choice for field screening methods.
Glutathione GSH is the most commonly used index of
biological stress status (Dalle-Donne et al. 2006). It is an
important intracellular scavenger of free radicals and
neutralizes peroxides in conjunction with GPx-1 and
glutathione reductase, thus maintaining the redox balance
of cells. Furthermore, GSH detoxifies electrophiles either
directly or via GST-catalyzed conjugation (Keen and
Jakoby 1978). Electrophilic compounds can enter erythro-
cytes in vitro and deplete erythrocyte GSH, which accounts
for >98% of the whole blood GSH store (Palmen and Evelo
1996). Because erythrocytes are the main source of GSH in
blood, GSH level will be significantly lower in anemic
patients with or without oxidative stress, therefore the
whole blood GSH concentration should be normalized
against hemoglobin level. Glutathione deficiency in whole
blood is associated with aging and the pathogenesis of
cardiovascular disease (Kharb 2003; Muda et al. 2003).
Conversely, high levels of total GSH in blood is found in
healthy elderly subjects (Pastore et al. 2003). Oxidative
stress caused by tobacco smoke has been reflected by
lowered levels of whole blood GSH, which increases
3 weeks after smoking cessation (Lane et al. 1996).
Likewise oxidative stress in chronic kidney disease is
associated with reduced blood and tissue GSH levels
(Vaziri 2004).
Measurement of both reduced and oxidized glutathione
(GSH/GSSG ratio) by spectrophotometry, spectrofluorometry,
and gas chromatography–mass spectrometry may be a useful
tool to assess the oxidative stress status in human blood.
However, the determination of GSSG in human blood could
easily be overestimated if samples are not properly pre-treated
with antioxidants during blood collection and blood sample
preparation (Rossi et al. 2002).
Lipid peroxidation products
Isoprostanes A comprehensive review on the analysis of
isoprostanes by immunologic, gas chromatography/mass
spectrometry (GC/MS), and high-performance liquid
chromatography (HPLC)/MS assays has been provided
by Lawson and FitzGerald (2002). 8-isoPGF2α is a major
component of a family of prostaglandin-like compounds
generated in vivo by nonenzymatic free radical-catalyzed
peroxidation product of arachidonic acid (Taber et al. 1997).
Most of the methods for F2-isoprostane quantification have
focused on the measurement of 8-isoPGF2α in biological
fluids (including human plasma) and are regarded as the gold
standard for the assessment of free radical-mediated lipid
peroxidation. 8-isoPGF2α determinations are carried out by
ultra-sensitive analytical techniques such as GC-MS or
HPLC-MS-MS (Milne et al. 2007). These methods have
the advantage to accurately quantify isoprostane concen-
trations down to the picomolar range, but require sample
preparation and expensive instrumentation. Immunoaffinity
chromatography is an efficient sample preparation method
linked to instrumental detection (HPLC-MS) (Sircar and
Subbaiah 2007). Less expensive antibody-based assays are
commercially available but lack specificity and matrix effects
of plasma samples can drastically affect the results. However,
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as with any analysis, the results are dependent on how the
samples were collected or handled, no matter how sophisti-
cated and expensive the applied analytical instrumentation
might be. In the case of isoprostane, the possibility of
artefactual isoprostane generation due to arachidonic acid
autooxidation requires precautionary measures to prevent ex
vivo oxidation in blood samples prior to analysis.
Malondialdehyde Malondialdehyde (MDA) can be exces-
sively generated after ROS-mediated lipid peroxidation
resulting in MDA-LDL adducts and damage to cell
membranes. MDA-LDL, in addition to oxidized low
density lipoprotein (oxLDL), is a key player in the
pathogenesis of atherosclerosis (Berliner and Heinecke
1996). Elevated plasma MDA levels were found in patients
with chronic heart failure (Diaz-Velez et al. 1996) and in
patients with end-stage renal disease (Vaziri 2004). An age-
dependent increase of erythrocyte MDA associated with a
decline of GSH has been observed (Gil et al. 2006; Rizvi
and Maurya 2007). In addition, several studies have
reported an increase of peripheral blood MDA in smokers
(Nielsen et al. 1997), in workers exposed to heavy metals
(Jiun and Hsien 1994), in nonsmoking bus drivers (Autrup
et al. 1999), and in female students after environmental
exposure to air pollutants (Sørensen et al. 2003).
The most widely used method to assess lipid peroxida-
tion is the thiobarbituric acid reactive substances (TBARS)
test. TBARS reacts with MDA to generate the MDA-
dithiobarbituric acid adduct. However, the TBARS assay
does not specifically measure MDA or lipid peroxidation
and therefore it has been criticized (Halliwell and Gutter-
idge 1999). Significant improvement can be made to the
TBARS technique by using HPLC to separate the MDA-
dithiobarbituric acid adduct (Halliwell and Whiteman
2004). Therefore, lipid peroxidation in plasma should be
evaluated by HPLC with fluorescence detection, which
quantifies only the actual MDA-dithiobarbituric acid adduct
(Lykkesfeldt 2001; Mao et al. 2006).
Oxidized low density lipoprotein Increased LDL oxidation
is believed to play a critical role in the pathogenesis
of atherosclerosis (Steinberg 1997; Heinecke 1998).
LDL can be oxidized to oxLDL in vitro and in vivo by
several mechanisms that affect apolipoprotein B function
(Steinbrecher et al. 1987; Mertens and Holvoet 2001).
The oxidative modification of LDL results in a distinc-
tive pattern of oxidation-specific epitopes for scavenger
receptors leading to macrophage foam cell formation (a key
event in the arterial subendothelium leading to the develop-
ment of atherosclerosis). Many studies indicate that circulating
oxLDL is significantly increased in patients with coronary
artery disease (Holvoet et al. 1998a, b; Toshima et al. 2000;
Shimada et al. 2004; Huang et al. 2008; Kazunori and
Hiroshi 2004) and those with end-stage renal disease (Vaziri
et al. 2009). Oxidized LDL was a predictor of incident
coronary artery disease in one cohort study (Meisinger et al.
2005); but in a large prospective cohort study, it was not an
independent predictor of coronary artery disease after
adjustment for LDL cholesterol, HDL cholesterol, and
apolipoprotein B (Wu et al. 2006). OxLDL may be important
in acute inflammatory events and as such could be a useful
biomarker of acute air pollution effects. Circulating oxLDL
has been suggested to be involved in the upregulation of
inflammatory genes (Berliner et al. 1995) and expression of
cytokines in human blood (Hulthe and Fagerberg 2002).
Binding of ox-LDL to its receptor on endothelial cells and on
macrophages leads to the expression of monocyte chemotac-
tic protein-1 and adhesion molecules. Additionally, ox-LDL
inhibits nitric oxide production and leads to endothelial
dysfunction and apoptosis (Li and Mehta 2000a, b) resulting
in oxidative stress and inflammation and thus promoting
atherogenesis (Cominacini et al. 2000; Mehta et al. 2006).
Oxidized LDL in plasma is usually measured with a
standardized competitive enzyme-linked immunosorbent
assay (ELISA) based on monoclonal antibodies directed
against a neo-epitope in the aldehyde-substituted apoB-100
moiety of LDL (mAB-4E6; oxLDL-4E6 assay, Mercodia
AB, Uppsala, Sweden).
Protein oxidation products
There is no single universal marker for oxidative (and/or)
nitrosative protein modification, because 20 different amino
acids may be attacked by ROS/RNS and there are 35 or
more ways in which proteins can be oxidized (Madian and
Regnier 2010). Nevertheless, protein oxidation products are
stable, have long half lives and sensitive assays are
available for detection (Dalle-Donne et al. 2006). Unlike
lipid peroxidation products, protein oxidation products
(such as carbonylated proteins and 3-nitrotyrosine) are not
subject to artificial oxidation during sample preparation and
during prolonged storage in a freezer.
Carbonylated proteins Many of the oxidative modifications
of proteins involve some type of carbonlyation, which may
result in the irreversible loss of protein function (Madian
and Regnier 2010). Thus, irreversible ROS-mediated
protein oxidation may be reflected by the accumulation of
protein carbonyl levels. An increase of carbonyl proteins
has been associated with aging and several human diseases
such as Alzheimer’s disease, diabetes, sepsis (Dalle-Donne
et al. 2003; Levine 2002), and chronic kidney disease
(Vaziri 2004). Protein carbonyl levels were significantly
higher in patients with chronic obstructive pulmonary
disease exposed to tobacco and biomass smoke than in a
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control group (Ceylan et al. 2006). This is consistent with
previous findings showing increased carbonyls in human
plasma induced by smoking cigarettes (Reznick et al. 1992;
Marangon et al. 1998, 1999). A more recent study reported
significant small positive correlations (R=0.30–0.31) of
PM2.5 and PM10 exposure with plasma carbonyl protein
concentrations in bus drivers, but adjusted regression
models were not tested (Rossner et al. 2007).
The protein carbonyl content is considered as the most
general and most commonly used index for protein
oxidation (Dalle-Donne et al. 2006). Furthermore, a meta-
analysis of published results revealed that in many cases
levels of protein carbonyls correlate directly with concen-
trations of lipid peroxidation products (Dotan et al. 2004).
Commercially available protein carbonyl ELISA kits can be
used for the direct measurement of DNPH-derivatized
carbonyl proteins. These assays use anti-DNP antibodies,
are reproducible, and correlate well with typical spectro-
photometric DNP assays (Rossner et al. 2007).
3-Nitrotyrosine Redox modifications of tyrosine residues to
3-nitrotyrosine by peroxynitrite and other reactive nitrogen
species, and by myeloperoxidase-mediated pathways, may
lead to disruption of signal transduction pathways mediated by
tyrosine phosphorylation, changes in enzyme activities in
biological systems, and nitrosative stress (Keng et al. 2000;
MacMillan-Crow et al. 1996). Thus, nitrotyrosination is
likely to be involved in atherogenesis and thus in the
pathology of cardiovascular diseases including coronary
artery disease (Beckmann et al. 1994; Shishehbor et al.
2003) among others. Exposure to cigarette smoke and diesel
exhaust particles induces protein nitration in vitro and in
animal models (Sanbongi et al. 2003; Xiao et al. 2005; Piperi
et al. 2003; Yamaguchi et al. 2000). Furthermore, higher
exposure to PM2.5 and PM10 showed significant small
positive correlations (R=0.29–0.30) with increased levels of
3-nitrotyrosine in plasma samples of bus drivers, but adjusted
regression models were not tested (Rossner et al. 2007).
The recommended method for plasma nitrotyrosine detec-
tion in plasma requires GC/MS or GC/MS/MS instrumenta-
tion (e.g., Tsikas and Caidahl 2005). However, less expensive
ELISA methods for screening 3-nitrotyrosine plasma have
been reported (Khan et al. 1998).
Plasma fluorescent oxidation products
Fluorescent oxidation products in human plasma may
represent a more global marker of oxidative stress for
epidemiologic studies reflecting stable protein oxidation,
advanced glycation end products, and advanced lipoxidation
end products (e.g., malondialdehyde; Wu et al. 2007a). They
have been associated with risk of coronary artery disease and
they were associated with several known promoters of
oxidative stress such as smoking and hypertension (Wu et
al. 2007b; Mezzetti et al. 2001). The chromophoric structures
responsible for the fluorescence are conjugated Schiff bases.
However, fluorescent oxidation products in plasma samples
cannot be measured directly but require extraction with
suitable organic solvents before spectrofluorometric analysis
(Shimasaki 1994; Wu et al. 2004).
Biomarkers of antioxidant activity
Humans have evolved various enzymatic defenses against
ROS generated endogenously (e.g., ROS generated by
mitochondrial electron respiratory chain, by monooxygenase
enzymes and by cell signaling processes) or originating
from external sources (e.g., exposure to redox cycling
agents present in air pollutants). More specifically,
cellular SOD (MnSOD, Cu,ZnSOD) reduces O2
− to
H2O2, then, in turn, catalase reduces H2O2 to water and
molecular oxygen in order to minimize oxidative damage.
Among other regulating functions, the selenium-dependent
GPx-1 catalyzes the reduction of H2O2 and lipid peroxides
to water and lipid alcohols by using the reducing power of
GSH.
Commercial test kits are available for measuring the
activities of SOD, GPX, and catalase in biological fluids by
monitoring the generation of end-products (colorimetric
end-point detection) or the decrease in the levels of
substrate (colorimetric, kinetic assays).
Other antioxidant enzymes that can be measured and are
potentially involved in effects of air pollutant exposures
include NQ01, HO-1, and PON1 as discussed above.
Transcriptional oxidative-stress response
The peripheral blood transcriptome could serve as a useful
biomarker of oxidative stress-related defense mechanisms in
combination with protein expression levels. Systemic
responses to air pollution can be measured in human
experimental or epidemiologic studies using gene expression
levels in leukocytes. In vitro data shows that inflammatory
response genes and antioxidant enzyme genes (CuZn-SOD,
HO-1, NQO1) are upregulated in human endothelial cells
exposed to diesel exhaust particles (Gong et al. 2007). These
effects were synergistically upregulated with co-exposure to
an oxidized phospholipid. HO-1 was also upregulated in liver
tissue of hypercholesterolemic mice exposed to urban
ultrafine particles (Gong et al. 2007). Most gene expression
and air pollution data has come from in vitro studies (Gong et
al. 2007; Hirano et al. 2003; Li et al. 2003; Wan and Diaz-
Sanchez 2006) or animal models (Gong et al. 2007; Kooter et
al. 2005), but it is unclear whether these findings can be
extrapolated to humans. There is little gene expression data
46 Air Qual Atmos Health (2011) 4:37–52
from human subjects to support the relevance of experimental
results (Wang et al. 2005; Peretz et al. 2007). An experimen-
tal study of five subjects showed upregulation of oxidative
stress-related genes including HO-1 after diesel exhaust
exposure (Peretz et al. 2007). An occupational study of
welders linked air pollutant exposure (metal fumes) to within-
subject changes in whole blood gene expression related to
inflammation and oxidative stress (Wang et al. 2005). Despite
a small sample size of 15 exposed welders, they found that
changes in gene expression profiling could be measured in
whole-blood total RNA using only one pair of pre- and
post-work shift samples. Most of the observed expression
variations were from only nine nonsmoking welders.
They found more up- or down-regulated genes (p<0.05)
in welders (533 genes) than in seven non-exposed controls
(86 genes).
An inherent limitation is that expression on a transcrip-
tion level does not necessarily reflect changes on the
(functional) protein level. Many transcripts are not being
actively translated. Moreover, functional expression
depends on protein-protein interactions and/or post-
translational modifications.
Conclusions
Most epidemiologic research has focused on available
exposure data including regulated PM2.5 mass and gasses
such as ozone, or general markers of fossil fuel and other
combustion sources such as black carbon. However, there is
mounting experimental evidence that particle components
that contribute little to overall particle mass have the
potential for pro-oxidant effects in the body (such as PAH)
leading to antioxidant responses, which when overwhelmed
at higher pollutant concentrations results in oxidative stress
and then inflammation. It is also possible that ultrafine
particles are more likely to induce systemic oxidative stress
and inflammation than larger particles and that this is
attributable to greater surface area and higher concentrations
of redox active components compared with the accumulation
mode fraction of PM2.5. However, there is little data on this
in human populations to conclude whether different particle
size fractions have different magnitudes of association with
oxidative stress outcomes. Similarly, it is unclear whether
there are differences in oxidative stress effects for two
general characteristics of organic PM and their precursor
volatile and semivolatile components, namely, primary
organic aerosols and associated chemicals from fossil
fuel combustion such as PAH (that have oxidant potential
after biotransformation) versus photochemical oxidants
on secondary aerosols such as polar organics. Transition
metals may have additional impacts on oxidative stress.
There is also limited data on the effects of volatile and
semi-volatile organic air pollutants in human populations,
especially electrophiles. Finally, the overall oxidant
potential of particulate and volatile pollutant mixtures
may be more informative with regard to health effects
that any specific set of components or source markers
(although these are clearly important to identify in efforts
to protect public health).
A variety of methods are available to measure oxidative
stress in the circulation. The best choice of biomarkers for
epidemiologic studies will depend on the research aims, but
the decision may be difficult based on the current literature. In
an epidemiological study where a large number of biospeci-
mens are collected, more accurate measurement methods may
be too costly. However, employing methods that are more
feasible (e.g., antibody-based assays for 8-isoPGF2α) may
result in semi-quantitative data and increased type II error
since the measurement error is likely to be unrelated to
exposure and the bias is thus towards the null hypothesis. A
large sample size may or may not overcome this type of
error. Furthermore, the ability to detect an exposure threshold
where the balance between oxidant defense and oxidation
of cell constituents is tipped toward oxidative stress may
be adversely influenced by the limit of detection for the
biomarker assay. Therefore, we believe there is a need
for a comprehensive assessment of the reliability and
validity of biomarkers of oxidative stress for large-scale
field studies.
The use of a longitudinal design with repeated measures
can enhance the representativeness of measurements and
information content, and thus increase the utility of more
feasible methods for the measurement of oxidative stress. The
cohort panel study is a design that is particularly well-suited to
the study of acute effects because with repeated measures,
each subject can act as their own control, thus reducing
variability from between-subject determinants of oxidative
stress. Panel studies are particularly suited to assess the time
course of exposure-response relations (from hourly to
daily or weekly averages and lags) and to evaluate
whether one biomarker of oxidative stress or antioxidant
response is more closely associated with specific pollut-
ant components than another is using within-subject data.
Systemic inflammatory and thrombotic mediators in the
blood as well as clinical outcomes should be measured
simultaneously to assess the impact of air pollutant-
related oxidative stress. Finally, transcriptomic and
epigenetic approaches can be used to test and explore
biological pathways that are relevant to these clinical and
biological outcomes.
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